Table 2.
Variables | Low risk for Gastric Cancer n=45 |
High risk for Gastric Cancer n=41 |
Two-tailed p-value * |
---|---|---|---|
Age in years, mean (SD) | 47.5(6.0) | 48.9(5.3) | 0.257 |
cagA assessment by PCR, n(%) | |||
Uninfected | 7(15.6) | 2(4.9) | 0.209 |
Negative | 6(13.3) | 4(9.7) | |
Positive | 32(71.1) | 35(85.4) | |
H. pylori genotypes, n(%) | |||
Uninfected | 7(15.6) | 2(4.9) | 0.079 |
cagA positive, vacA s1m1** | 29(64.4) | 35(85.4) | |
Other genotypes | 9 (20.0) | 4 (9.7) | |
H. pylori genotypes, n(%) | |||
Uninfected | 7(15.6) | 2(4.9) | 0.128 |
cagA negative | 6(13.3) | 4(9.7) | |
cagA positive, 3 EPIYAs | 25(55.6) | 21(51.2) | |
cagA positive, >3 EPIYAs | 7(15.5) | 14(34.2) | |
H. pylori genotypes, n(%) | |||
uninfected | 7(15.6) | 2(4.9) | 0.076 |
cagA positive, (3 EPIYAs), vacA s1m1* | 7(15.6) | 14(34.2) | |
cagA positive (>3 EPIYAs) vacA s1m1* | 22(48.8) | 21(51.2) | |
other genotypes | 9(20.0) | 4(9.7) | |
Histopathological diagnosis§ , n(%) | |||
Normal/NAG | 27(61.4) | 13(31.7) | 0.021 |
MAG | 6(13.6) | 8(19.5) | |
IM/Dysplasia | 11(25.0) | 20(48.8) | |
% methylation, median (interquartile range) | |||
RPRM | 14(7) | 21(7.5) | <0.001 |
APC | 25(8) | 23(9) | 0.9158 |
MGMT | 54(12) | 58(11) | 0.3788 |
TWIST1 | 8 (2) | 10(4) | <0.001 |
Mathematically transformed values of % methylation, mean (SD) |
|||
RPRM (logarithm) | 2.6(0.4) | 3.0(0.3) | <0.001 |
APC (logarithm) | 3.2(0.3) | 3.2(0.2) | 0.9460 |
MGMT(square-root) | 3160(848.4) | 3369(906.6) | 0.2869 |
TWIST1(inverse) | 0.10 (0.03) | 0.13 (0.03) | <0.001 |
Abbreviations: SD= standard deviation; NAG: non-atrophic gastritis; MAG: multifocal atrophic gastritis; IM: intestinal metaplasia.
p-value from χ2, Fisher's exact, t test or Wilcoxon/Mann-Whitney test as appropriate.
This category includes a subject with a strain of H. pylori that was cagA positive and vacA s1, but which repeatedly failed PCR for vacA m.
A subject with gastritis in which we could not assess atrophy was excluded from this analysis.